I was reading somewhere there need about $100M or so.
CR is off the cards as it will be too dilutive so it’s a partnership/licensing type deal IMO - they have already given up low teens % royalties (from memory) already so possibly they can given away another 15% in exchange for some more cash
Ann: Opthea Completes Enrollment in Phase 3 Clinical Program, page-23
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
0.020(4.88%) |
Mkt cap ! $529.3M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 43.5¢ | 40.3¢ | $838.5K | 2.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18064 | 43.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 29017 | 1 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| OPT (ASX) Chart |